Doha: Healthcare experts from across Qatar gathered for a Weill Cornell Medicine-Qatar (WCM-Q) interprofessional education event that discussed strategies to optimize medication safety for patients in healthcare settings primary and outpatient in Qatar.
The Optimizing Medication Safety in Primary and Ambulatory Care Settings event was coordinated by the Continuing Professional Development (CPD) Division of WCM-Q and featured expert speakers from academia, the public health sector and the private sector.
During the event, held on the WCM-Q virtual platform, speakers described risk factors for adverse drug events and medication errors, explained why and how the implications for medication safety occur in the prescribing, dispensing, and administration processes in primary care settings, and describes strategies to reduce medication safety implications at interfaces of care, particularly during admission , transfer and discharge of patients. Speakers also identified and discussed specific and significant drug safety issues that have arisen in Qatar during the COVID-19 pandemic and outlined strategies to minimize drug safety implications resulting from the pandemic.
The course directors for the event were Dr. Phyllis Muffuh Navti, Associate Director of Continuing Professional Development at WCM-Q and clinical pharmacist; Dr. Anas Hamad, Director of Pharmacy and Head of Drug Safety/Quality at Hamad Medical Corporation (HMC); and Dr. Manal Al-Zaidan, Director of Pharmacy at the Primary Health Care Corporation (PHCC). The three course directors were also expert speakers at the event.
Dr Navti said, “Medication safety is of paramount importance to patient safety and optimal healthcare outcomes. As such, pharmacists and other healthcare professionals must continually review procedures to ensure that medications are prescribed, dispensed and managed correctly. This educational event provided an excellent opportunity to discuss strategies to optimize medication safety, which is particularly timely given that the COVID-19 pandemic has forced many healthcare institutions to change the way they prescribe and dispense. drugs and has also reduced the possibilities of advising patients on safe drugs. use.”
Other expert speakers were Dr. Mai Mahmoud, associate dean for faculty affairs at WCM-Q and specialist geriatrician; Ebtesam Abdulla, Nursing Affairs Specialist at PHCC; and Mr. Vyas S. Kattezhathu, Director of Pharmacy Academics and Senior Pharmacist at Wellcare Pharmacy. Three female students also participated: Maryam Idris, final year medical student at WCM-Q, Maya Kriel, third year nursing student at the University of Calgary in Qatar, and Shareefa Nalupurappattil Mullakkeettil Moideen, pharmacy student at the College . of Pharmacy from Qatar University.
The event was accredited locally by the Department of Health Professions of the Ministry of Public Health – Accreditation Section and internationally by the Accreditation Council for Continuing Medical Education (ACCME).
About Weill Cornell Medicine – Qatar
Weill Cornell Medicine – Qatar is a partnership between Cornell University and the Qatar Foundation. It offers a comprehensive six-year medical program leading to the Cornell University medical degree with instruction from Professors Cornell and Weill Cornell and physicians from Hamad Medical Corporation (HMC), Aspetar Orthopedic and Sports Hospital Medicine, Primary Health Care Corporation, Feto Maternal Center and Sidra Medicine, who hold positions at Weill Cornell. Through its biomedical research program, WCM-Q is building a sustainable research community in Qatar while advancing basic science and clinical research. Through its Faculty of Medicine, WCM-Q seeks to provide the best possible education for medical students, to improve current and future health care, and to provide high quality health care to the people of Qatar.
For more information, please contact:
Associate Director, Media and Publications
Weill Cornell Medicine – Qatar